HLA-A and neoplasm: Furthermore, PBMC from leukemia patients were found to have lower HLA-A*02:01 expression levels than PBMC from healthy donors (Supplementary Figure S7); downregulation of HLA expression is one of the mechanisms of tumor immune evasion [55].